Skip to content

Clinical trials

Phase 1 Hepatitis B trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 1 Country / region: New Zealand Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20123
20142
20151
20162
20172
20183
20201
20211
20221
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated5
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences4
Alios Biopharma Inc.3
Assembly Biosciences3
Alnylam Pharmaceuticals1
Arrowhead Pharmaceuticals1
Enanta Pharmaceuticals, Inc1
Epigenic Therapeutics, Inc1
Hoffmann-La Roche1
Inovio Pharmaceuticals1
IntegerBio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B20
Hepatitis B, Chronic13
Hepatitis3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.